Although VEGFB’s potential therapeutic role in heart failure remains promising, current evidence is limited to preclinical investigations, and further research is needed to fully understand its mechanisms of action, such that VEGFB-mediated targeted interventions can be developed. This evidence concerns the gene VEGFB and heart failure.